Identification of a new HLA-A2–restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma

This publication has 53 references indexed in Scilit:

• Generation of Potent Antitumor CTL from Patients with Multiple Myeloma Directed against HM1.24
  Clinical Cancer Research, 2005
• Post‐transplantation tumour load in bone marrow, as assessed by quantitative ASO‐PCR, is a prognostic parameter in multiple myeloma
  British Journal of Haematology, 2004
• A gene atlas of the mouse and human protein-encoding transcriptomes
  Proceedings of the National Academy of Sciences, 2004
• Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
  New England Journal of Medicine, 2003
• Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy
  Leukemia, 2003
• Reactive plasmacytoses, a model for studying the biology of human plasma cell progenitors and precursors
  The Hematology Journal, 2000
• Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma Cells
  Biochemical and Biophysical Research Communications, 1999
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
  Nucleic Acids Research, 1997
• Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).
  The Journal of Experimental Medicine, 1996